The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NSABP B-51/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC.
Eleftherios P. Mamounas
No relevant relationships to disclose
Julia R. White
No relevant relationships to disclose
Hanna Bandos
No relevant relationships to disclose
Thomas B. Julian
No relevant relationships to disclose
Atif J. Kahn
No relevant relationships to disclose
Simona Flora Shaitelman
No relevant relationships to disclose
Mylin Ann Torres
No relevant relationships to disclose
Susan Ann McCloskey
No relevant relationships to disclose
Frank A. Vicini
No relevant relationships to disclose
Patricia A. Ganz
No relevant relationships to disclose
Soonmyung Paik
No relevant relationships to disclose
Nilendu Gupta
No relevant relationships to disclose
Joseph P. Costantino
No relevant relationships to disclose
Walter John Curran
No relevant relationships to disclose
Norman Wolmark
No relevant relationships to disclose